Moody Aldrich Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47M Sell
146,077
-37,361
-20% -$1.39M 0.98% 36
2026
Q1
$6.66M Buy
183,438
+73,023
+66% +$3.26M 1.2% 16
2025
Q4
$5.14M Sell
110,415
-5,128
-4% -$228K 0.96% 33
2025
Q3
$4.81M Sell
115,543
-22,253
-16% -$712K 0.91% 40
2025
Q2
$3.96M Sell
137,796
-2,109
-2% -$65.1K 0.77% 63
2025
Q1
$4.69M Sell
139,905
-4,461
-3% -$167K 0.98% 38
2024
Q4
$7.38M Buy
144,366
+5,236
+4% +$293K 1.37% 16
2024
Q3
$7.11M Sell
139,130
-11,053
-7% -$570K 1.29% 23
2024
Q2
$6.73M Buy
150,183
+93,781
+166% +$4.33M 1.31% 16
2024
Q1
$2.64M Buy
+56,402
New +$2.21M 0.45% 82
2023
Q4
Sell
-61,979
Closed -$1.84M 202
2023
Q3
$1.84M Buy
+61,979
New +$1.28M 0.35% 91

Other funds holding CRNX